- Home
- RSSS vs BOLD Comparison
RSSS vs BOLD Comparison
Compare RSSS & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- BOLD
- Stock Information
- Founded
- RSSS 2006
- BOLD 2018
- Country
- RSSS United States
- BOLD United States
- Employees
- RSSS N/A
- BOLD N/A
- Industry
- RSSS Business Services
- BOLD
- Sector
- RSSS Consumer Discretionary
- BOLD
- Exchange
- RSSS Nasdaq
- BOLD Nasdaq
- Market Cap
- RSSS 86.4M
- BOLD 81.0M
- IPO Year
- RSSS N/A
- BOLD 2024
- Fundamental
- Price
- RSSS $2.68
- BOLD $2.95
- Analyst Decision
- RSSS Strong Buy
- BOLD Strong Buy
- Analyst Count
- RSSS 1
- BOLD 3
- Target Price
- RSSS $6.00
- BOLD $23.00
- AVG Volume (30 Days)
- RSSS 30.4K
- BOLD 57.8K
- Earning Date
- RSSS 11-07-2024
- BOLD 11-11-2024
- Dividend Yield
- RSSS N/A
- BOLD N/A
- EPS Growth
- RSSS N/A
- BOLD N/A
- EPS
- RSSS N/A
- BOLD N/A
- Revenue
- RSSS $44,623,899.00
- BOLD N/A
- Revenue This Year
- RSSS $13.76
- BOLD N/A
- Revenue Next Year
- RSSS $9.92
- BOLD N/A
- P/E Ratio
- RSSS N/A
- BOLD N/A
- Revenue Growth
- RSSS 18.35
- BOLD N/A
- 52 Week Low
- RSSS $2.21
- BOLD $2.82
- 52 Week High
- RSSS $3.50
- BOLD $15.24
- Technical
- Relative Strength Index (RSI)
- RSSS 50.43
- BOLD N/A
- Support Level
- RSSS $2.55
- BOLD N/A
- Resistance Level
- RSSS $2.75
- BOLD N/A
- Average True Range (ATR)
- RSSS 0.10
- BOLD 0.00
- MACD
- RSSS -0.00
- BOLD 0.00
- Stochastic Oscillator
- RSSS 53.57
- BOLD 0.00
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.